Back to Superinvestors
SUPERINVESTOR HOLDERS
NBIX
Neurocrine Biosciences Inc
Healthcare · Drug Manufacturers - Specialty & Generic
- Holders
- 5
- Total value
- $1,777,512,542
- Total shares
- 10,546,846
- Cross-link
- Financials →
| Investor | Shares | Value | % of Portfolio | Activity | As of |
|---|---|---|---|---|---|
|
Dodge & Cox
Dodge & Cox
|
5,584,707 | $941,218,594 | 0.49% | ADD +123,670 | 30 Jun 2026 |
|
Cliff Asness
AQR Capital Management
|
3,818,037 | $643,472,716 | 0.22% | REDUCE -1,120,930 | 30 Jun 2026 |
|
PRIMECAP Management
PRIMECAP Management Co
|
491,340 | $82,807,988 | 0.05% | REDUCE -5,000 | 30 Jun 2026 |
|
Joel Greenblatt
Gotham Asset Management
|
371,568 | $62,622,213 | 0.15% | ADD +11,432 | 30 Jun 2026 |
|
Hersh Cohen
ClearBridge Investments
|
281,194 | $47,391,031 | 0.04% | REDUCE -28,841 | 30 Jun 2026 |